Moderate to Severe Plaque Psoriasis (PsO) Results Photos| TREMFYA® (guselkumab) HCP

VOYAGE 2

IN PATIENTS WITH MODERATE TO SEVERE PLAQUE PSORIASIS
PICTURES OF RESULTS WITH TREMFYA®1*

WEEK 0

Photos of a patient with plaque psoriasis before and after taking TREMFYA® (guselkumab)

PASI=32.8

WEEK 16

Photos of a patient with plaque psoriasis before and after taking TREMFYA® (guselkumab)

PASI=8.4

WEEK 48

Photos of a patient with plaque psoriasis before and after taking TREMFYA® (guselkumab)

PASI=2.8

Age 36
BMI 31.1 kg/m2
Baseline BSA involvement 54%
Psoriasis duration 12 years
Previous therapies topicals, biologics

*Individual results may vary. Plaque psoriasis photos are of a real patient from VOYAGE 2 who received TREMFYA® 100 mg at Weeks 0 and 4, and q8w thereafter through Week 48. Other areas affected (not shown) yielded similar results to those depicted here. Images are for illustrative purposes only and are used with permission from Janssen Biotech, Inc.

Reference: 1. Data on file. Janssen Biotech, Inc.